CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

An expert panel of the Central Drugs Standard Control Organisation on Monday recommended granting permission to manufacture and market anti-Covid pill Molnupiravir for restricted emergency use for......

Govt approves 2 new vaccines, Covid drug for emergency use

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drugs Standard Control Organisation (CDSCO) has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological......

5 more manufacturers to produce black fungus drug: Govt

The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing......

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

It is one of 42 drug-making factories in India that the FDA has banned in recent years The US Food and Drug Administration (FDA) has warned Indian generic drugmaker Emcure Pharmaceuticals, saying......

MNCs look towards India for a booster dose

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......

4 IPOs to watch out for in 2022

Once stability returns to the secondary market, companies that have obtained approval from  Sebi will start tapping the market. Sundar Sethuraman & Samie Modak report. Illustration: Dominic......

Sun-Ranbaxy $4 billion merger completed

Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries on Tuesday said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals. In a......